1. Home
  2. MVBF vs SERA Comparison

MVBF vs SERA Comparison

Compare MVBF & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MVB Financial Corp.

MVBF

MVB Financial Corp.

HOLD

Current Price

$27.67

Market Cap

351.9M

Sector

Finance

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$3.48

Market Cap

130.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MVBF
SERA
Founded
1997
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
351.9M
130.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MVBF
SERA
Price
$27.67
$3.48
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$27.60
N/A
AVG Volume (30 Days)
83.3K
57.1K
Earning Date
10-29-2025
11-13-2025
Dividend Yield
2.49%
N/A
EPS Growth
73.99
N/A
EPS
2.45
N/A
Revenue
$167,853,000.00
$95,000.00
Revenue This Year
N/A
$19.22
Revenue Next Year
$14.06
$400.00
P/E Ratio
$11.17
N/A
Revenue Growth
18.75
1.06
52 Week Low
$15.59
$1.37
52 Week High
$28.96
$9.13

Technical Indicators

Market Signals
Indicator
MVBF
SERA
Relative Strength Index (RSI) 52.63 57.92
Support Level $26.52 $3.20
Resistance Level $28.96 $3.70
Average True Range (ATR) 0.81 0.28
MACD 0.03 0.04
Stochastic Oscillator 48.31 76.93

Price Performance

Historical Comparison
MVBF
SERA

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: